GJB1 and X-linked Charcot-Marie-Tooth disease type 1: Interestingly, it appears that restoring Cx32 function in at least 50% of myelinating Schwann cells in PNS tissues may be sufficient to provide significant functional and morphological improvement in this model and potentially also in CMT1X patients.